Goldfarb RH - Search Results

1

A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin.

Goldfarb RH, Koelemij R, Muirhead KA, Ohlsson-Wilhelm BM, Gray BD, Kuppen PJ, Basse PH, al-Atrash G, Kitson RP. Goldfarb RH, et al. In Vivo. 2000 Jan-Feb;14(1):101-4. In Vivo. 2000. PMID: 10757065

2

Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).

Chen WS, Kitson RP, Goldfarb RH. Chen WS, et al. Among authors: goldfarb rh. In Vivo. 2002 Nov-Dec;16(6):439-45. In Vivo. 2002. PMID: 12494887

3

Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.

Datta A, Kitson RP, Xue Y, al-Atrash G, Mazar AP, Jones TR, Goldfarb RH. Datta A, et al. Among authors: goldfarb rh. In Vivo. 2002 Nov-Dec;16(6):451-7. In Vivo. 2002. PMID: 12494889

4

Neuroendocrine modulation of tumor metastases. I. Effect of adrenalectomy on B16 melanoma metastases.

Kitson RP, Brunson KW, Miller CA, Goldfarb RH. Kitson RP, et al. Among authors: goldfarb rh. In Vivo. 1994 Nov-Dec;8(5):803-6. In Vivo. 1994. PMID: 7727728

5

Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.

Brunson KW, Ohashi M, Miller CA, Kitson RP, Basse PH, Goldfarb RH. Brunson KW, et al. Among authors: goldfarb rh. In Vivo. 1994 Jan-Feb;8(1):71-5. In Vivo. 1994. PMID: 8054514

6

Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide.

Goldfarb RH, Ohashi M, Brunson KW, Kirii Y, Kotera Y, Basse PH, Kitson RP. Goldfarb RH, et al. Anticancer Res. 1998 May-Jun;18(3A):1441-6. Anticancer Res. 1998. PMID: 9673353

7

Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progression.

Goldfarb RH, Albertsson P, Nannmark U, Kitson RP. Goldfarb RH, et al. In Vivo. 1998 Nov-Dec;12(6):589-92. In Vivo. 1998. PMID: 9891221

8

Flavone acetic acid enhances accumulation of IL-2 activated NK cells within established metastases.

Kitson RP, Ohashi M, Brunson KW, Goldfarb RH. Kitson RP, et al. Among authors: goldfarb rh. In Vivo. 1998 Nov-Dec;12(6):593-7. In Vivo. 1998. PMID: 9891222

9

Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.

Goldfarb RH, Kitson RP, Brunson KW, Yoshino K, Hirota N, Kirii Y, Kotera Y, Inoue Y, Ohashi M. Goldfarb RH, et al. Anticancer Res. 1999 May-Jun;19(3A):1663-7. Anticancer Res. 1999. PMID: 10470098

10

Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains.

Kitson RP, Lu M, Siman R, Goldfarb RH. Kitson RP, et al. Among authors: goldfarb rh. In Vivo. 2000 Jan-Feb;14(1):265-8. In Vivo. 2000. PMID: 10757085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters